Ozempic Face: There's a Fix for That

Demand for semiglutide drugs, better known as Ozempic and Wegovy, has soared over the past year as the public learned of its weight loss properties.  Studies have shown that it can cut body weight by 15%, and Novo Norodisk, the maker of both drugs has reported that 81% of pitients using it are women.ast year.

It’s ability to melt away stubborn pounds in the span of a few weeks is pretty incredible—but like anything else that seems too good to be true, there's a catch: Ozempic Face.

Characterized by gaunt, deflated cheeks and loose, sagging skin around the jowls, it's an unfortunate (and unfortunately common) side effect of this trending weight loss drug. For women whose cheeks were plump as grapes pre-Ozempic, watching them shrivel into raisins can be nothing short of devastating. And for that? There is a medispa fix for that called Sofwave.

Sofwave is a safe, non-invasive option for men and women turning to Ozempic who still want to keep their natural facial volume. The innovative treatment remodels collagen and improves facial lines and wrinkles with cutting-edge ultrasound technology.

“Ozempic face is becoming more and more common. One major concern is what will happen when people discontinue using a semiglutide and then regain weight,” says New York City dermatologist Doris Day MD. “Rapid weight loss and yo-yo dieting, for any reason, can affect skin elasticity and aging. Sofwave is a great option for firming and lifting and can address some of the issues around rapid volume loss.”

Sofwave’s unique SUPERB Technology heats collagen at the right temperature triggering a healing response that increases both collagen and elastin in the skin, which is necessary to maintain volume. Sofwave is FDA-cleared to lift the eyebrows, lax skin under the chin and neck tissue in addition to reducing fine lines and wrinkles. The trailblazing technology works on all skin types and tones, and it's safe and comfortable, requiring only a topical anesthetic to numb the skin. After just one 45-minute in-office treatment, patients show significant improvement in 12 weeks.